8 min read
Monthly FDA Guidance and Regulatory News Review - August 2026
This August 2026 regulatory update focuses on the FDA finalizing three guidances addressing formal sponsor meetings,...
Meet Veristat at SCOPE: Powering the Future of Clinical Research February 2-5, 2026
đŸ”¬ Advancing Clinical Research with Strategic Partnership
Veristat is proud to be attending SCOPE 2026, where industry leaders gather to shape the future of clinical trials, data strategy, and operational excellence. As the clinical development landscape evolves and expectations rise, our team is ready to forge new collaborations and share insights that accelerate progress and improve outcomes.
đŸ‘¥ Meet the Veristat Team at SCOPE
Connect with our experts to explore how Veristat’s tailored solutions can advance your clinical and regulatory milestones:
-
Kim Boerike, Chief Operating Officer
-
AJ Mills, Vice President, Global Commercial
-
Caroline Hyde, Business Development Manager
-
Ryan Butcher, Team Lead, Account Development
đŸ“… Schedule a meeting in advance
By completing the form on this page. We welcome the opportunity to discuss your upcoming programs and how Veristat can be a strategic partner in your success.
đŸ’¡ Our Expertise
Whether you're launching a first-in-human study or navigating complex regulatory pathways, Veristat delivers integrated expertise and personalized support across the development lifecycle:
Let’s shape the future of clinical research—together.
Schedule A Meeting
Meet with us at SCOPE: Powering the Future of Clinical Research February 2-5, 2026
8 min read
Monthly FDA Guidance and Regulatory News Review - July 2026
Aug 14, 2026 Veristat Blog
This July 2026 regulatory update focuses on the FDA finalizing six guidances that addresses antiviral next-generation...